Young Jin Lee
Young Jin Lee has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Minn Sohn
Lactomason Co., Ltd., Jinju 52840, Korea
3 shared publications - Tae-Rahk Kim
Lactomason Co., Ltd., Jinju 52840, Korea
3 shared publications - So Lim Shin
Microbiome R&D Center Lactomason Seoul Republic of Korea
2 shared publications - Won-Young Bae
Department of Food Science and Biotechnology of Animal Resources Konkuk University Seoul Korea
2 shared publications - Woo-Hyun Jung
Microbiome R&D Center, Lactomason Co. Ltd., Jinju 52840, Korea
2 shared publications Bo Su Lee
R&D Center, Unigen, Inc., Cheonan, Korea
1 shared publication
Latest Publications
- Open Access
- 1 July 2024
- Published by Springer Nature in Food Science of Animal Resources
- Vol. 44 (4) , 951-965
Lactiplantibacillus plantarum LM1001 Improves Digestibility of Branched-Chain Amino Acids in Whey Proteins and Promotes Myogenesis in C2C12 Myotubes
Food Science of Animal Resources (Food Sci. Anim. Resour.) is an international, peer-reviewed bimonthly journal publishing original research and reviews on basic and applied aspects of the use of animal resources including the meat, egg, dairy, and edible insect/worm products. Food Sci. Anim. Resour. is published and distributed by the Korean Society for Food Science of Animal Resources.
- 1 July 2024
- Published by Springer Nature in Food Science of Animal Resources
- Vol. 44 (4) , 951-965
Open AccessLactiplantibacillus plantarum LM1001 Improves Digestibility of Branched-Chain Amino Acids in Whey Proteins and Promotes Myogenesis in C2C12 Myotubes
Food Science of Animal Resources (Food Sci. Anim. Resour.) is an international, peer-reviewed bimonthly journal publishing original research and reviews on basic and applied aspects of the use of animal resources including the meat, egg, dairy, and edible insect/worm products. Food Sci. Anim. Resour. is published and distributed by the Korean Society for Food Science of Animal Resources.
- Open Access
- 1 January 2024
- Published by XMLink in Yonsei Medical Journal
- Vol. 65 (12) , 727-740
Effects of Lactiplantibacillus plantarum LM1215 on Candida albicans and Gardnerella vaginalis
Bae WY, et al. Yonsei Med J. 2024 Aug;65:e58. https://doi.org/10.3349/ymj.2023.0490
- 1 January 2024
- Published by XMLink in Yonsei Medical Journal
- Vol. 65 (12) , 727-740
Open AccessEffects of Lactiplantibacillus plantarum LM1215 on Candida albicans and Gardnerella vaginalis
Bae WY, et al. Yonsei Med J. 2024 Aug;65:e58. https://doi.org/10.3349/ymj.2023.0490
- Open Access
- 1 January 2024
- Published by XMLink in Food Supplements and Biomaterials for Health
- Vol. 4 (1)
Comparison of Ginseng Leaf Extract and Its Acid-Treated Form, UG0712 Between Their Effects on Exercise Performance in Mice
Lee YJ, et al. Food Suppl Biomater Health. 2024 Mar;4:e4. https://doi.org/10.52361/fsbh.2024.4.e4
- 1 January 2024
- Published by XMLink in Food Supplements and Biomaterials for Health
- Vol. 4 (1)
Open AccessComparison of Ginseng Leaf Extract and Its Acid-Treated Form, UG0712 Between Their Effects on Exercise Performance in Mice
Lee YJ, et al. Food Suppl Biomater Health. 2024 Mar;4:e4. https://doi.org/10.52361/fsbh.2024.4.e4
- Open Access
- 12 May 2023
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 22 (11) , 3125-3134
Heat‐treated Pediococcus acidilactici LM1013‐mediated inhibition of biofilm formation by Cutibacterium acnes and its application in acne vulgaris: A single‐arm clinical trial
Purpose: Acne vulgaris is a common skin disease accompanied by chronic inflammation in the pilosebaceous follicles, resulting from excessive Cutibacterium acnes. This study aimed to investigate the inhibition of biofilm formation by C. acnes ATCC 6919 using heat‐treated Pediococcus acidilactici LM1013 (HT‐LM1013), previously isolated from the Korean traditional fermented alcoholic beverage—makgeolli, and its application as a leave‐on‐type product for patients with acne vulgaris.Methods: HT‐LM1013 was prepared by Lactomason and homogenized using a high‐pressure homogenizer. The minimum inhibitory concentration (MIC), tricarboxylic acid (TCA) cycle, and lipase activity were evaluated for C. acnes inhibition. Inhibition of biofilm formation was demonstrated using a crystal violet solution. Damaged C. acnes was observed using field‐emission scanning electron microscopy (FE‐SEM). Clinical trials were performed using a leave‐on‐type product containing HT‐LM1013.Results: HT‐LM1013 inhibited the TCA cycle (36.80%) and lipase activity using palmitate (31.89%), stearate (36.91%), and oleate (30.86%) as substrates at 1 × MIC (p < 0.01). After treatment with HT‐LM1013, concave and elongated shapes of C. acnes were observed by FE‐SEM. In addition, HT‐LM1013 inhibited biofilm formation by 71.75% at 1 × MIC (p < 0.001) and removed 73.35% of mature biofilms (p < 0.01). In the clinical trial, the leave‐on‐type product decreased the number of closed comedones from 14.04 to 10.22, open comedones from 7.22 to 4.39%, and sebum content to 76.23% at week 4 (p < 0.01). The satisfaction score of the participants was recorded 3.83 on a five‐point scale.Conclusion: HT‐LM1013 is potent for the treatment of acne vulgaris.
- 12 May 2023
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 22 (11) , 3125-3134
Open AccessHeat‐treated Pediococcus acidilactici LM1013‐mediated inhibition of biofilm formation by Cutibacterium acnes and its application in acne vulgaris: A single‐arm clinical trial
Purpose: Acne vulgaris is a common skin disease accompanied by chronic inflammation in the pilosebaceous follicles, resulting from excessive Cutibacterium acnes. This study aimed to investigate the inhibition of biofilm formation by C. acnes ATCC 6919 using heat‐treated Pediococcus acidilactici LM1013 (HT‐LM1013), previously isolated from the Korean traditional fermented alcoholic beverage—makgeolli, and its application as a leave‐on‐type product for patients with acne vulgaris.Methods: HT‐LM1013 was prepared by Lactomason and homogenized using a high‐pressure homogenizer. The minimum inhibitory concentration (MIC), tricarboxylic acid (TCA) cycle, and lipase activity were evaluated for C. acnes inhibition. Inhibition of biofilm formation was demonstrated using a crystal violet solution. Damaged C. acnes was observed using field‐emission scanning electron microscopy (FE‐SEM). Clinical trials were performed using a leave‐on‐type product containing HT‐LM1013.Results: HT‐LM1013 inhibited the TCA cycle (36.80%) and lipase activity using palmitate (31.89%), stearate (36.91%), and oleate (30.86%) as substrates at 1 × MIC (p < 0.01). After treatment with HT‐LM1013, concave and elongated shapes of C. acnes were observed by FE‐SEM. In addition, HT‐LM1013 inhibited biofilm formation by 71.75% at 1 × MIC (p < 0.001) and removed 73.35% of mature biofilms (p < 0.01). In the clinical trial, the leave‐on‐type product decreased the number of closed comedones from 14.04 to 10.22, open comedones from 7.22 to 4.39%, and sebum content to 76.23% at week 4 (p < 0.01). The satisfaction score of the participants was recorded 3.83 on a five‐point scale.Conclusion: HT‐LM1013 is potent for the treatment of acne vulgaris.